Cargando…
Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
The advent of biologics and small molecules in inflammatory bowel disease (IBD) has marked a significant turning point in the prognosis of IBD, decreasing the rates of corticosteroid dependence, hospitalizations and improving overall quality of life. The introduction of biosimilars has also increase...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037250/ https://www.ncbi.nlm.nih.gov/pubmed/36970587 http://dx.doi.org/10.3748/wjg.v29.i10.1539 |